Shared decision-making in prostate cancer treatment: selecting an androgen deprivation therapy option

Future Oncol. 2026 May;22(12):1341-1345. doi: 10.1080/14796694.2026.2665606. Epub 2026 May 15.

Abstract

This podcast will provide an overview of androgen deprivation therapy (ADT) for advanced prostate cancer, including the different treatment options currently available. The podcast will also cover the key results of recently published studies that looked at patient preferences for different characteristics of ADT. Additionally, a physician and patient will each discuss the importance of shared decision-making in selecting the optimal ADT option. They will address key factors to discuss when evaluating ADT options, and emphasize the importance of aligning treatment choices with patients' individual needs and the best available scientific evidence.

Keywords: Advanced prostate cancer; GnRH agonists; GnRH antagonists; androgen deprivation therapy; patient preferences; podcast; shared decision-making.

Publication types

  • Review

MeSH terms

  • Androgen Antagonists* / therapeutic use
  • Antineoplastic Agents, Hormonal* / therapeutic use
  • Decision Making, Shared*
  • Humans
  • Male
  • Patient Preference
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / therapy

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal